# Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

> **NCT02431481** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 38 (actual)

## Conditions studied

- Normal Renal Function
- Impaired Renal Function

## Interventions

- **DRUG:** LEE011

## Key facts

- **NCT ID:** NCT02431481
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-23
- **Primary completion:** 2017-09-14
- **Final completion:** 2018-05-11
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02431481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02431481, "Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02431481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*